Arog Pharmaceuticals, Inc. IPO Research Information

Arog Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Arog Pharmaceuticals, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Arog Pharmaceuticals, Inc.	AROG - NASDAQ	Withdrawn	$0.00	$0.00	Withdrawn
Underwriter(s): Citigroup, RBC Capital, Nomura
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-09-28 Withdrawn 2019-09-17

About Arog Pharmaceuticals, Inc. (adapted from Arog Pharmaceuticals, Inc. prospectus):
They are a late-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AROG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.